Connection between Endometriosis and Vitamin D – True or False?

Endometriosis is a serious health problem character ized by the persistence and growth of vascularized tissue at va rious ectopic sites such as ovaries, bowel, or bladder. Despite decades of i ntensive research, we are not making significant progress toward the etiology or treatment of this disease. The question of risk factor is similarly u nclear, with one possible factor being diet-particularly the intake of vitami n D. In addition, as endometriosis has some similarities and clear conne ctions to cancer, where vitamin D is heavily studied, this relation started to be a subject of intensive research in this field, too. The overall aim of thi s study is to review possible links between vitamin D intake and endometriosis.

Endometriosis, Vitamin D, Receptor, Ovaries, Female

Endometriosis is a chronic disease with estimated prevalence of 10% (Missmer and Cramer, 2003). Despite the seriousness and long-term research interests, the etiology of endometriosis is still p oorly understood. However, immunological aspects are gaining more and more attention (Kralickova and Vetvicka, 2015) and the search for reliable markers is still ongoing, with few clearly defined markers (Kralickova and Vetvicka, 2016). The question of ri sk factor is similarly unclear, with one possible fact or being diet-particularly the intake of vitamin D. Vitamin D Vitamin D is an essential steroid pro-hormone playing an important role in maintenance of phospha te and calcium homeostasis. Despite the “vitamin” name , its source is not completely dietary and over 85% i s generated in the skin following exposure to ultravi olet light. For detailed description of chemistry and biological effects of vitamin D, see an excellent review by Nandi et al. (2016). Besides the principal role in bone homeostasis, vitamin D is involved in additional biological processes such as modulation of cell growth, immune functions and reduction of inflammation. In addition, vitamin D affects in vitro insulin and follicle-stimulating, hormone-induced secretion of progesterone (Smolikova et al ., 2013). Vitamin D is also heavily involved in human reproduction, from fertility outcome to semen quali ty (for review, Anagnostis et al ., 2013). Proposed roles of vitamin D in women’s reproduction are summarized in a report by Grundmann and von Versen-Hoynck (2011). A clinical study found small and nonsignificant increase in 1,25-hydroxyvitamin D levels in patient s with endometriosis with a slight trend towards high er levels according to the severity of the disease (Somigliana et al ., 2007). Later, a prospective cohort study of 70,556 women with endometriosis, evaluated over the period of 14 years, investigated whether t he plasma 1,25-hydroxyvitamin D levels were associated with the disease. The results suggested that greate r plasma levels of vitamin D and higher intake of dai ry foods are clearly associated with decreased risk of endometriosis (Harris et al ., 2013). This study, which estimated serum values of 1- α,25-hydroxyvitamin D3 and calculated variables such as race, age, physica l activity or alcohol intake, showed inverse associat ion between 1- α,25-hydroxyvitamin D3 values and endometriosis and women with the highest levels had Králíčková Milena and Vetvicka Vaclav / American Journa l of Immunology 2017, 13 (2): 127.130 DOI: 10.3844/ajisp.2017.127.130 128 24% lower risk of endometriosis (Harris et al ., 2013). On the other hand, a recent study found 1- α,25- hydroxyvitamin D3 levels significantly lower in ser um of patients with severe endometriosis (Miyashita et al ., 2016), further confusing the question of whether vi tamin D levels are important. The importance of 1- α,25-hydroxyvitamin D3 levels was confirmed using experimental model of rats with endometriotic implants. Animals with 1- α,25- hydroxyvitamin D3 showed significantly lesser symptoms, leading to the conclusion that this molec ule resulted in regression via altering implant levels of VEGF, TIMP-2 and MMP-9 (Yildirim et al ., 2014). Human clinical trials will be needed to confirm the possibility of treatment. An interesting observatio n by Agic et al. (2007) of very high metabolism of vitamin D in the endometrium suggested possible paracrine act ion of vitamin D. This hypothesis was supported by find ings that Elocalcitol, a vitamin D receptor agonist, can reverse endometriotic implants in animal models (Mariani et al ., 2012). An in vitro study focusing on the possible effects of 1-α,25-hydroxyvitamin D3 on human endometriotic stromal cells isolated from ovarian endometrioma demonstrated that the addition of 1- α,25- hydroxyvitamin D3 resulted in reduction of IL-1 β- and TNF- α-induced inflammatory responses and reduction of numbers of viable stromal cells (Miyashita et al ., 2016). If these results are confirmed, supplementation with vitamin D might represent a novel strategy. Another hypothesis suggested that endometriosis is an autoimmune disease. With the known autocrine/paracrine action of vitamin D and established relation between autoimmune diseases and vitamin D, Peterlik and Cross (2005) focused their attention on vitamin D a s an immunomodulator. The problems with any clear relations result from the fact that endometriosis i s associated with normal or elevated levels of 1- α,25- hydroxyvitamin D3 and not with any deficiency. The only possibility would be local effects, which woul d be missed on fluid evaluation such as serum. Additiona l hypotheses about vitamin D and endometriosis are summarized in a recent review (Sayegh et al., 2014). Vitamin D-Binding Protein Vitamin D-binding protein (also called Gc-globulin or DBP) is a multifunctional protein deeply involve d in transport of vitamin D sterols and in modulation of inflammation and defense reactions. Due to the suspected role of inflammation and several immune aspects in the development of endometriosis, this protein was also evaluated in women with endometriosis. However, the levels of this protein both in serum and in peritoneum were not significantly different between control and endometriosis groups (Borkowski et al ., 2008). 2-D electrophoresis was used for evaluation of DBP levels in peritoneal fluid and plasma. One isoform (DBPE) showed lower levels in sampled peritoneal fl uid, but when the patients were treated with oral contraceptive, the levels of DBPE returned to norma l (Ferrero et al ., 2005), making the possibility of DBP involvement even more confusing. Using proteomics, elevated levels of vitamin D- binding protein were found in urine of women with endometriosis (Cho et al ., 2012), suggesting that urine samples might be utilized in further investigations and that this protein might play a role in endometriosi s. A different experimental approach, combining 2-DE gel electrophoresis with mass spectrometry, was later used to compare endometrial protein in ectopic endometrial tissue and normal endometrial tissue. Among fifteen other proteins, levels of vitamin D- binding protein were found to be significantly incr eased in ectopic endometrium, suggesting that this protei n can have a direct role in the progression of this disea se (Hwang et al ., 2013). Human cycling endometrium has been shown to express vitamin D receptor (Vigano et al ., 2006). This receptor is a nuclear ligand-inducible transcriptio n factor and in complex with vitamin D, it regulates express ion of more than 900 different genes (Carlberg, 2003). A comparative histological study showed strong staining for vitamin D receptor in endometriosis an d endometrial cancer, with the strongest staining in epithelial cells. In addition, these samples also s howed stronger expression of vitamin D 1 α-hydroxylase (Agic et al ., 2007). The authors hypothesized that vitamin D might affect local action of immune cells and/or secretion of cytokines involved in developme nt of endometriosis. Elocalcitol, a selective vitamin D receptor agonist , reduced endometriosis development in mouse model vi a inhibition of peritoneal inflammation (Mariani et al ., 2012), demonstrated by inhibition of macrophage inf lux and inhibition of secretion of inflammatory cytokines. Genetic alterations in the Vitamin D Receptor (VDR) gene might lead to biologically relevant defects in gene activation with subsequent changes in immune functions. Detailed analysis of vitamin D receptor gene polymorphism in women suffering from endometriosis revealed no changes between patients and controls, strongly demonstrating that VDR polymorphism is not involved in endometriosis (Lima Vilarino et al ., 2011). Proteolytic analysis of serum found 3x higher level of vitamin D-binding protein in patients with Králíčková Milena and Vetvicka Vaclav / American Journa l of Immunology 2017, 13 (2): 127.130 DOI: 10.3844/ajisp.2017.127.130 129 endometriosis. Subsequent analysis of specific alle le products showed that the most commonly expressed protein is GC*2 allele product. As this product is not converted to a macrophage-stimulating factor, the authors hypothesize that the inability to stimulate macrophages to optimally phagocytose-invading

results in allowing the endometriotic tiss ue to seed the peritoneal cavity (Faserl et al ., 2011). Gene Level Endometrium is a target of 1- α,25-hydroxyvitamin D3 actions via regulation of specific genes, most probably HOXA10 gene expression. This gene is cyclically expressed in adult endometrium in respon se to estrogens. 1- α,25-hydroxyvitamin D3 can induce HOXA10 transcription through VDR binding to its responsive elements in the HOXA10 gene 5 region, which might subsequently induce differentiation of endometrial cells to decidual cells (Du et al ., 2005). Lower expression of this gene was found in the euto pic and ectopic endometrium of endometriosis (Deng et al ., 2011). However, a study evaluating VDR polymorphism found no association between this polymorphism and endometriosis or infertility (Villarino et al ., 2011). Another vitamin D-regulated gene is osteopontin gene, with higher expression in eutopic endometrium (Cho et al ., 2009). The 1 α-hydroxylase (enzyme necessary to catalyze the synthesis of 1- α,25-hydroxyvitamin D3) mRNA is expressed in ectopic endometrium and its levels are increased in proliferative phase cultures derived f rom women with endometriosis. These data suggested that cycling endometrium might be included among the extrarenal sites able to synthesize vitamin D (Vigano et al ., 2006).

Endometriosis was first described more than 150 years ago (Von Rokitansky, 1860), but the causes an d treatments remain enigmatic and the search for responsible molecules is still ongoing. Numerous studies suggest some kind of vitamin D involvement in the pathogenesis of endometriosis, but direct pr oof is still elusive. Several studies have found altere d levels of vitamin D in patients suffering from endometriosis; however, no clear benefits from supplementation with vitamin D have been established. On the other hand, despite intensive research, we are not closer to understanding the pathogenesis of endometriosis than we were decades ago and there is still a need to fully confirm or d isprove the functional role of the vitamin D system at the endometrial level. The hopes that vitamin D will represent the Golden Fleece seem to be unsubstantiated. Financial Support and Sponsorship Nil. Author’s Contributions Milena Kralickova: Designed the article, wrote the manuscript. Vaclav Vetvicka: Designed the article, wrote the manuscript. Conflicts of Interest There are no conflicts of interest.

Agic, A., H. Xu, C. Altgassen, F. Noack and M.M. Wolfler et al ., 2007. Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D 1 α- hydroxylase, vitamin D 24-hydroxylase and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers. Reprod. Sci., 14: 486-497. DOI: 10.1177/1933719107304565 Anagnostis, P., S. Karras and D.G. Goulis, 2013. Vitamin D in human reproduction: A narrative review. Int. J. Clin. Pract., 67: 225-235. DOI: 10.1111/ijcp.12031 Borkowski, J., G.B. Gmzrek, J.P. Madej, W. Nowacki and M. Goluda et al ., 2008. Serum and peritoneal evaluation of vitamin D-binding protein in women with endometriosis. Postepy Hig. Med. Dosw., 62: 103-109. PMID: 18334925 Carlberg, C., 2003. Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands. Rece nt Res. Canc. Res., 164: 29-42. PMID: 12899512 Cho, S., Y.S. Ahn, Y.S. Choi, A. Nam and H.Y. Kim et al ., 2009. Endometrial osteopontin mRNA expression and plasma osteopontin levels are increased in patients with endometriosis. Am. J. Reprod. Immunol., 61: 286-293. DOI: 10.1111/j.1600-0897.2009.00692.x Cho, S.H., Y.S. Choi, S.Y. Yim, H.I. Yang and J.E. Jeon et al ., 2012. Urinary vitamin D-binding protein is elevated in patients with endometriosis. Human Reprod., 27: 515-552. DOI: 10.1093/humrep/der345 Deng, K.X., X.C. Liu and Y.H. Zheng, 2011. Expression and significance of HOXA10 gene in the eutopic and ectopic endometrium of endometriosis. Zhonghua Fu Chan KkeZaZhi, 46: 813-816. PMID: 22333228 Du, H., G.S. Daftary, S.I. Lalwani and H.S. Taylor, 2005. Direct regulation of HOXA10 by 1- α,25- (OH)2D3 in human myelomonocytic cells and human endometrial stromal cells. Mol. Endocrinol., 19: 222-233. DOI: 10.1210/me.2004-0336 Králíčková Milena and Vetvicka Vaclav / American Journa l of Immunology 2017, 13 (2): 127.130 DOI: 10.3844/ajisp.2017.127.130 130 Faserl, K., G. Golderer, L. Kremser, H. Lindner and B. Sarg et al ., 2011. Polymorphism in vitamin D- binding protein as a genetic risk factor in the pathogenesis of endometriosis. J. Clin. Endocrinol. Metab., 96: E233-E241. DOI: 10.1210/jc.2010-1532 Ferrero, S., D.J. Gillott, P. Anserini, V. Remorgid a and K.M. Price et al ., 2005. Vitamin D binding protein in endometriosis. J. Soc. Gynecol. Invest., 12: 272-277. DOI: 10.1016/j.jsgi.2005.01.027 Grundmann, M. and F. von Hersen-Hoynck, 2011. Vitamin D-roles in women’s reproductive health? Reprod. Biol. Endocrinol., 9: 146-146. DOI: 10.1186/1477-7827-9-146 Harris, H.R., J.E. Chavarro, S. Malspels, W.C. Will ett and S.A. Missmer, 2013. Dairy-food, calcium, magnesium and vitamin D intake and endometriosis: A prospective cohort study. Am. J. Epidemiol., 177: 420-430. DOI: 10.1093/aje/kws247 Hwang, J.H., T. Wang, K.S. Lee, J.K. Joo and H.G. L ee, 2013. Vitamin D binding protein plays an important role in the progression of endometriosis. Int. J. M ol. Med., 32: 1394-1400. DOI: 10.3892/ijmm.2013.1506 Kralickova, M. and V. Vetvicka, 2015. Immunological aspects of endometriosis: A review. Ann. Transl. Med. DOI: 10.3978/j.issn.2305-5839.2015.06.08 Kralickova, M. and V. Vetvicka, 2016. Endometriosis - Search for biomarkers. Am. J. Immunol., 12: 43-48. DOI: 10.3844/ajisp.2016.43.48. 44 Lima Vilarino, F., B. Bianco, T. Goberstein Lerner, J. Souto Teles and F. Abani Mafra et al ., 2011. Analysis of vitamin D receptor gene polymorphisms in women with and without endometriosis. Human Immunol., 72: 359-363. DOI: 10.1016/j.humimm.2011.01.006 Mariani, M., P. Vigano, D. Gentilini, B. Camisa and E. Caporizzo et al ., 2012. The selective vitamin D receptor agonist, elocalcitol, reduces endometriosi s development in a mouse model by inhibiting peritoneal inflammation. Hum. Reprod., 27: 2010-2019. DOI: 10.1093/humrep/des150 Missmer, S.A. and D.W. Cramer, 2003. The epidemiology of endometriosis. Obstet. Gynecol. Clin. North Am., 30: 1-19. DOI: 10.1016/S0889-8545(02)00050-5 Miyashita, M., K. Koga, G. Izui, F. Sue and T. Makabe et al ., 2016. Effects of 1,25- hydroxyvitamin D 3 on endometriosis. J. Clin. Endocrinol. Metab., 101: 2371-2379. DOI: 10.1210/jc.2016-1515 Nandi, A., N. Sinha, E. Ong, H. Sonmez and L. Poretsky, 2016. Is there a role for vitamin D in human reproduction? Horm. Mol. Biol. Clin. Invest., 25: 15-28. DOI: 10.1515/hmbci-2015-0051 Peterlik, M. and H.S. Cross, 2005. Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur. J. Clin. Invest., 35: 290-304. DOI: 10.1111/j.1365-2362.2005.01487.x Sayegh, L., G. El-Haji Fuleihan and A.H. Nassar, 20 14. Vitamin D in endometriosis: A causative or confounding factor? Metabolism, 63: 32-41. DOI: 10.1016/j.metabol.2013.09.012 Smolikova, K., A. Mlynarcikova and S. Scsukova, 201 3. Effects of 1 α,25-dihydroxyvitamin D, on progesterone secretion by porcine ovarian granulosa cells. Endocrine Reg., 47: 123-131. PMID: 23889482 Somigliana, E., P. Panina-Bordignon, S. Murone, P. Di Lucia and P. Vercellini et al ., 2007. Vitamin D reserve is higher in women with endometriosis. Human Reprod, 22: 2274-2278. DOI: 10.1093/humrep/dem142 Vigano, P., D. Lattuada, S. Mangioni, L. Ermellino and M. Vignali et al ., 2006. Cycling and early pregnant endometrium as a site of regulated expression of th e vitamin D system. J. Mol. Endocrinol., 36: 415-424. DOI: 10.1677/jme.1.01946 Villarino, F.L., B. Bianco, T.G. Lerner, J.S. Teles and F.A. Mafra et al ., 2011. Analysis of vitamin D receptor gene polymorphism in women with and without endometriosis. Human Immunol., 72: 359-363. DOI: 10.1016/j.humimm.2011.01.006 Von Rokitansky, C., 1860. Uber uterusdrusen- neuerbildungin uterus and ovarilsarcomen. Z. Gesselschaft. Aerzte Wien, 37: 577-593. Yildirim, B., T. Guler, M. Akbulut, O. Oztekin and G. Sarliz, 2014. 1- α,25-hydroxyvitamin D3 regresses endometriotic implants in rats by inhibiting neurovasculatization and altering regulation of matrix metalloproteinases. Postgraduate Med., 126: 104-110.